Shares of Invivyd (NASDAQ:IVVD) closed 42% increased Friday after the biotech firm introduced it had obtained FDA emergency use authorization, or EUA, for its COVID-19 prophylactic drug Pemgarda and launched Part...
Invivyd, Inc. (NASDAQ:IVVD) Q2 2023 Earnings Convention Name August 10, 2023 4:30 PM ET Firm Members Gabriella Linville-Engler - Investor Relations Dave Hering - Chief Monetary Officer Pete Schmidt - Chief Medical...
